The Duke does it again. A spot on prediction "the market could open 500 points down on the 24th"
$HW 400 Puts for July 18 bought Thursday. But today only single digit trades in June and July. Both bigs are holding. Sold off early but has climbed back to $18 in a big down market.
sheep got slaughtered today on ABBV. Najarian was pumping it as late as last Friday. Results published in a weekend conference of one of their drugs. OTIC is expected to release some info on a dosage trial, here in June. I just don't know what day.
$HW has 2,388 open interest on June $19 Call Strike. Alerted on options monster as unusual.
The only specific item that I can see is the possible sale of their declining oil construction business.
On the earnings call, I believed they were asked about it, and they replied over the next 12 months.
The options were selling at .50 but since have come down to .25
and what are you greek? a troll? another 5% today and I didn't trade at all. I have been holding. Did I tell you to buy now? No. I just said, shut your face.
OTIC posted when then went to analyst meetings. They told you that they were approved. If you listened to the Medicare meeting one of them said they had the C approval. Then a couple of days later, boom, it's announced, a month early. I looked and listened to all of them. It's called due diligence. Quite frankly I was expecting insider sales, but none have appeared yet.
LOL what's your metric Greek? I made a lot of money on JKS, every year, for years. JKS is easy to trade. And I don't even short stocks. I don't have my life savings in OTIC. and have sold shares. I have a base and a trade up or down. That's how you play Bio, because only the huge companies have profits. Look at GNCA, that is a pure pumper Bio stock and their product will probably never come to market. Shut your face. You never knew where the bottom was with OTIC and you have the balls to keep posting here. Your a joke. And I get an alert every time you respond to me. Fool!
from what I can tell. UBS doesn't cover GNCA. Perhaps coverage will begin soon after today.
lol is that what you paid for it $30? That's the life of bio and pharma stocks, big moves.
You missed a 17% move and you were all over this stock. You blew it.
And comparing this to VRX just shows that you don't know anything! Go away, your dismissed!
is the move over? Well the big conference is going on now in Chicago with lots of rich doctors who also want returns on their investments. Trading in your own industry is the best way to stay wealthy, if you can stay objective when things are not totally clear. Such as knowing how many actual tube placements with this product will take place?
The chart resistance didn't get hit on Friday. Room to run as they say. Then the true test. If it beaks through, we are off to the races. There are a few light targets and if the low volume returns then by Wed we will know IMO.
so much for the lock-up expiration sell off. Doesn't that mean it's time for a takeover rumor, so they can offload? Those Square devices are little white things. I-Square ?
lame - from the Fly - Square initiated at Piper Jaffray Square initiated with a Neutral at Piper Jaffray. Piper Jaffray analyst Jason Deleeuw started Square with a Neutral rating and $10 price target. The analyst has questions around Square's long-term profitability and believes its business model will need to evolve.
it's of comfort that the institutional investors didn't dump and run. They are in it for the long run, big returns. The short term traders lost.